Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia-Septicemia Model in Rats

Antibiotics
Hessel Van der WeideIrma A J M Bakker-Woudenberg

Abstract

Background: Recent scientific reports on the use of high dose tigecycline monotherapy as a "drug of last resort" warrant further research into the use of this regimen for the treatment of severe multidrug-resistant, Gram-negative bacterial infections. In the current study, the therapeutic efficacy of tigecycline monotherapy was investigated and compared to meropenem monotherapy in a newly developed rat model of fatal lobar pneumonia-septicemia. Methods: A Klebsiella pneumoniae producing extended-spectrum β-lactamase (ESBL) and an isogenic variant producing K. pneumoniae carbapenemase (KPC) were used in the study. Both strains were tested for their in vitro antibiotic susceptibility and used to induce pneumonia-septicemia in rats, which was characterized using disease progression parameters. Therapy with tigecycline or meropenem was initiated at the moment that rats suffered from progressive infection and was administered 12-hourly over 10 days. The pharmacokinetics of meropenem were determined in infected rats. Results: In rats with ESBL pneumonia-septicemia, the minimum dosage of meropenem achieving survival of all rats was 25 mg/kg/day. However, in rats with KPC pneumonia-septicemia, this meropenem dosage was unsuccessful. In...Continue Reading

References

May 1, 1996·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M T Nüesch-InderbinenF H Kayser
Oct 6, 2000·Clinical Pharmacokinetics·J W MoutonA A Vinks
Jun 19, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Patricia A BradfordJohn Quale
Dec 24, 2004·Antimicrobial Agents and Chemotherapy·Gopal MuralidharanSteven Troy
Nov 15, 2005·The Journal of Antimicrobial Chemotherapy·Neil WoodfordMatthew J Ellington
Sep 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David P Nicolau
Nov 26, 2008·Antimicrobial Agents and Chemotherapy·Delphine GirlichPatrice Nordmann
Mar 13, 2009·International Journal of Antimicrobial Agents·Olaf BurkhardtTobias Welte
Jan 15, 2010·The Journal of Antimicrobial Chemotherapy·Caroline DallenneGuillaume Arlet
Feb 23, 2010·Annals of Hematology·Herwig PieringerErich Pohanka
Feb 24, 2010·Computer Methods and Programs in Biomedicine·Yong ZhangShaofei Xie
May 14, 2010·The New England Journal of Medicine·Anton Y Peleg, David C Hooper
Sep 18, 2010·Diagnostic Microbiology and Infectious Disease·Antonio T FreireUNKNOWN 311 Study Group
Oct 16, 2010·The Journal of Antimicrobial Chemotherapy·Jurriaan E M de SteenwinkelIrma A J M Bakker-Woudenberg
Mar 17, 2012·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M A IslamH P Endtz
Mar 8, 2014·International Journal of Antimicrobial Agents·Matthew E FalagasGiannoula S Tansarli
Jun 3, 2014·Critical Care : the Official Journal of the Critical Care Forum·Gennaro De PascaleMassimo Antonelli
Jun 17, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D van DuinR A Bonomo
Sep 10, 2014·Annals of the New York Academy of Sciences·Elizabeth TemkinYehuda Carmeli
Sep 23, 2014·International Journal of Antimicrobial Agents·Christina RoutsiHelen Giamarellou
Dec 31, 2014·Antimicrobial Agents and Chemotherapy·Qian ZhangJing Zhou
Jan 1, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C Hennequin, F Robin
Jan 30, 2016·Critical Care : the Official Journal of the Critical Care Forum·Matteo BassettiRichard G Wunderink
Sep 22, 2016·The Journal of Antimicrobial Chemotherapy·Marilena TsalaJoseph Meletiadis
Jun 14, 2017·Antimicrobial Agents and Chemotherapy·Jiao XieYalin Dong
Jun 16, 2017·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Alan AbdullaBirgit C P Koch
Aug 27, 2017·International Journal of Antimicrobial Agents·Maddalena GiannellaUNKNOWN Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva (ISGRI-SITA)
Dec 8, 2017·Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology·Fulya Yılmaz DuranEmre Mehmet Şen
Mar 10, 2018·Journal of Clinical Medicine·Jeffrey BaronBurke A Cunha

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Software Mentioned

ARRIVE
Prism
HiMLST
PKSolver

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.